The filing excerpts provided do not contain sufficient business detail to construct a supported canonical description for CG Oncology Inc (NASDAQ: CGON). The excerpts consist only of SEC cover page boilerplate and do not disclose the company's core business activity, revenue model, products, customers, competitors, or financial data. A description cannot be written without fabricating facts not present in the source material.

Source: SEC 10-K, filed 2026-02-27

Industry: Biological Products, (No Diagnostic Substances) Peers: Vericel Corp Celldex Therapeutics Inc Beam Therapeutics Inc Veracyte Inc Iovance Biotherapeutics Inc Intellia Therapeutics Inc Protagonist Therapeutics Inc Apogee Therapeutics Inc